HISTOTYPE PX Trademark

Trademark Overview

On Thursday, September 1, 2022, a trademark application was filed for HISTOTYPE PX with the United States Patent and Trademark Office. The USPTO has given the HISTOTYPE PX trademark a serial number of 79351121. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, February 21, 2024. This trademark is owned by DOMORE DIAGNOSTICS AS. The HISTOTYPE PX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Performing diagnosis of diseases; medical analysis services for cancer diagnosis and prognosis; providing cancer screening services
histotype px

General Information

Serial Number79351121
Word MarkHISTOTYPE PX
Filing DateThursday, September 1, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, February 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPerforming diagnosis of diseases; medical analysis services for cancer diagnosis and prognosis; providing cancer screening services

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 30, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDOMORE DIAGNOSTICS AS
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNO

Trademark Events

Event DateEvent Description
Thursday, September 29, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 30, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 4, 2022APPLICATION FILING RECEIPT MAILED
Monday, June 19, 2023ASSIGNED TO EXAMINER
Tuesday, July 4, 2023NON-FINAL ACTION WRITTEN
Wednesday, July 5, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, August 9, 2023REFUSAL PROCESSED BY MPU
Wednesday, August 9, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 28, 2023REFUSAL PROCESSED BY IB
Wednesday, February 21, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, February 21, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, February 21, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, March 25, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, February 22, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, February 24, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 14, 2025FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

histotype services cancer diagnosis prognosis screening providing analysis diseases medical performing